New Study on Dual Use of Cigarettes and E-Cigarettes.

Nov.07.2022
New Study on Dual Use of Cigarettes and E-Cigarettes.
A new study published in the Addiction journal found that dual users of e-cigarettes and combustible cigarettes have lower levels of toxic chemicals.

A new study published in the scientific journal Addiction suggests that individuals who use nicotine vapor products or electronic cigarettes while trying to quit smoking have lower levels of toxic chemicals in their bodies. The study analyzed the biomarkers of nearly 1,300 individuals who either smoked traditional cigarettes, used e-cigarettes, or used both in what is known as dual use. The researchers found that compared to traditional cigarette smokers, those who used both products had lower levels of toxic chemicals such as carbon monoxide in their bodies. This contradicts previous beliefs that using e-cigarettes as a smoking cessation method would lead to increased smoking and greater exposure to harmful chemicals from both traditional and electronic cigarettes.


What is "dual use"? Dual use refers to continuing to smoke traditional cigarettes even after starting to use electronic cigarettes. This has become a common practice among those attempting to quit smoking using electronic cigarettes. Many opponents of electronic cigarettes point to the prevalence of dual use as evidence that electronic cigarettes do not help people quit smoking, but rather encourage the development of another harmful habit: vaping.


It cannot be denied that many people are smoking traditional cigarettes and using e-cigarettes simultaneously. Numerous studies in the past two years have repeatedly found that people attempting to quit smoking by using e-cigarettes continue to smoke traditional cigarettes. Additionally, researchers pointed out that the success rate of dual users quitting either traditional cigarettes or e-cigarettes is not higher than those who use nicotine replacement therapy.


Many studies over the past decade have consistently shown that electronic cigarette users frequently engage in dual use, meaning they continue to smoke traditional tobacco cigarettes while using e-cigarettes. This is the case in the United States, United Kingdom, and European Union. For example, American smokers report that e-cigarette use has remained unchanged for three consecutive years, dropping only slightly from 29.8% in 2015 to 27.7% in 2018.


A similar report exists in the United Kingdom as well. A study revealed that the rate of dual use of electronic and traditional cigarettes is higher among teenagers who only use e-cigarettes, despite them being the largest group in the survey. The research also showed that young people who started with traditional cigarettes are more likely to continue to smoke them even after starting to use e-cigarettes.


Many people from different countries and backgrounds, regardless of race and gender, engage in dual use behavior, which seemed to reinforce the belief that e-cigarettes are not helpful for quitting smoking. However, this new study overturns this assumption by stating that dual use is only a transition, not a permanent one.


Is Dual Use of Tobacco and E-cigarettes Risky? Many studies have hinted at the potential danger of using both tobacco and e-cigarettes simultaneously. For instance, one study suggests that the likelihood of developing cardiovascular diseases is higher in individuals who use both products compared to those who only use e-cigarettes but lower than those who only smoke tobacco. However, new evidence from a recent study reveals the opposite.


A new study has examined the levels of carbon monoxide in the breath of cigarette smokers, e-cigarette users and those who use both. The study found that the levels of carbon monoxide in the bodies of those who only use e-cigarettes were lower than those who smoke cigarettes or use both. However, compared to those who only smoke cigarettes, those who use both also had lower levels of carbon monoxide in their bodies.


Another study found that dual users were more likely to quit smoking after a period of time, rather than returning to using only one type or quitting altogether. However, the study also found that, aside from dual use, there were other factors that caused them to stop smoking, unrelated to whether they smoked cigarettes. This study also suggests that those who smoke cigarettes and use electronic cigarettes usually return to only smoking cigarettes.


Can e-cigarettes help you quit smoking? Despite new research, many public health organizations and policymakers are unlikely to change their views on e-cigarettes, at least in America. However, despite the risks, countries like the UK have already adopted e-cigarettes as another tool to help people quit more harmful smoking habits.


Although this new study does offer new evidence in support of the notion that dual smoking is not as harmful as smoking cigarettes alone, it is not definitive proof. Other factors aside from using electronic cigarettes or vaping are relevant in determining whether an individual can successfully quit smoking. However, this study does indicate that going through a transitional period during the process of quitting smoking is harmless.


Statement:


This article is compiled from third-party information and is intended for industry discussion and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The compilation of this article is intended only for industry exchange and research.


Due to limitations in our translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


Regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions, 2FIRSTS remains fully aligned with the Chinese government.


The compilation of information is the property of the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24